. Author manuscript; available in PMC: 2021 May 1.

Published in final edited form as: Int J Gynecol Pathol. 2020 May;39(3):261–269. doi: 10.1097/PGP.0000000000000604

Table 1: Reasons for risk reducing surgery (note that categories are not exclusive; e.g. cases may have both a BRCA mutation and a family history of breast/ovarian cancer).

Total Cases	101
Cases with BRCA1 or BRCA2 mutations	61 (59.4%)
BRCA1	34 (33.7%)
BRCA2	27 (44.3%)
Patients with other genetic mutations associated with breast/ovarian cancer	2 (2.0%)
Patients with a known family history of breast/ovarian cancer	83 (82.2%)
Patients with a known personal history of breast cancer	25 (24.8%)